» Articles » PMID: 17589804

Human Cytomegalovirus Induces Cellular Tyrosine Kinase Signaling and Promotes Glioma Cell Invasiveness

Overview
Journal J Neurooncol
Publisher Springer
Date 2007 Jun 26
PMID 17589804
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Given our previous findings that human cytomegalovirus (HCMV) nucleic acids and proteins are expressed in human malignant glioma in vivo, we investigated cellular signaling events associated with HCMV infection of human glioma and astroglial cells. HCMV infection caused rapid activation of the phosphatidylinositol-3 kinase (PI-3K) effector AKT kinase in human astro-glial and fibroblast cells, and induced tyrosine phosphorylation of phospholipase Cgamma (PLCgamma). Co-immunoprecipitation experiments revealed association of the p85 regulatory subunit of PI-3K with a high-molecular weight protein phosphorylated on tyrosine, following short-term exposure to HCMV. In contrast to a previous report, we were unable to confirm the identity of this high-molecular weight protein as being the epidermal growth factor receptor (EGFR). Stimulation of glioma and fibroblast cell lines over-expressing EGFR with HCMV (whole virus) or soluble glycoprotein B did not induce tyrosine phosphorylation of the receptor, as did the genuine ligand, EGF. Furthermore, we found that expression levels of the human ErbB1-4 receptors were not rate-limiting for HCMV infection. Dispensability of EGFR function during early HCMV infection was substantiated by demonstration of viral immediate early gene expression in cells lacking the EGFR gene, indicating that HCMV may promote oncogenic signaling pathways independently of EGFR activation. Among non-receptor cellular kinases, HCMV infection induced phosphorylation of focal adhesion kinase (FAK) Tyr397, which is indispensable for integrin-mediated cell migration and invasion. HCMV-induced FAK activation was paralleled by increased extracellular matrix-dependent migration of human malignant glioma but not normal astro-glial cells, suggesting that HCMV can selectively augment glioma cell invasiveness.

Citing Articles

Classification and function of γδT cells and its research progress in anti-glioblastoma.

Zhao Y, Zhu R, Wang Y, Wang K Discov Oncol. 2023; 14(1):150.

PMID: 37597083 PMC: 10439874. DOI: 10.1007/s12672-023-00770-8.


Human cytomegalovirus in cancer: the mechanism of HCMV-induced carcinogenesis and its therapeutic potential.

Yu C, He S, Zhu W, Ru P, Ge X, Govindasamy K Front Cell Infect Microbiol. 2023; 13:1202138.

PMID: 37424781 PMC: 10327488. DOI: 10.3389/fcimb.2023.1202138.


Interplay Between Calcium and AMPK Signaling in Human Cytomegalovirus Infection.

Dunn D, Munger J Front Cell Infect Microbiol. 2020; 10:384.

PMID: 32850483 PMC: 7403205. DOI: 10.3389/fcimb.2020.00384.


Clinically Relevant Immune Responses against Cytomegalovirus: Implications for Precision Medicine.

Lerias J, Paraschoudi G, Silva I, Martins J, de Sousa E, Condeco C Int J Mol Sci. 2019; 20(8).

PMID: 31018546 PMC: 6514820. DOI: 10.3390/ijms20081986.


The role of CMV in glioblastoma and implications for immunotherapeutic strategies.

Rahman M, Dastmalchi F, Karachi A, Mitchell D Oncoimmunology. 2018; 8(1):e1514921.

PMID: 30546954 PMC: 6287786. DOI: 10.1080/2162402X.2018.1514921.


References
1.
Demuth T, Berens M . Molecular mechanisms of glioma cell migration and invasion. J Neurooncol. 2005; 70(2):217-28. DOI: 10.1007/s11060-004-2751-6. View

2.
Schlessinger J . Cell signaling by receptor tyrosine kinases. Cell. 2000; 103(2):211-25. DOI: 10.1016/s0092-8674(00)00114-8. View

3.
Threadgill D, Dlugosz A, Hansen L, Tennenbaum T, Lichti U, Yee D . Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science. 1995; 269(5221):230-4. DOI: 10.1126/science.7618084. View

4.
Harkins L, Volk A, Samanta M, Mikolaenko I, Britt W, Bland K . Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet. 2002; 360(9345):1557-63. DOI: 10.1016/S0140-6736(02)11524-8. View

5.
Blume-Jensen P, Hunter T . Oncogenic kinase signalling. Nature. 2001; 411(6835):355-65. DOI: 10.1038/35077225. View